[
    [
        {
            "time": "2021-05-10",
            "original_text": "华大基因(300676.SZ)：NUPCO继续追加3817.6万美元的合同金额",
            "features": {
                "keywords": [
                    "华大基因",
                    "NUPCO",
                    "合同金额",
                    "追加"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "华大基因(300676.SZ)：NUPCO继续追加3817.6万美元的合同金额",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-05-10",
            "original_text": "华大基因(300676)2020年年报及2021年一季报点评：新冠检测驱动业绩高速增长 精准医疗一体化解决方案供应商",
            "features": {
                "keywords": [
                    "华大基因",
                    "新冠检测",
                    "业绩增长",
                    "精准医疗"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华大基因(300676)2020年年报及2021年一季报点评：新冠检测驱动业绩高速增长 精准医疗一体化解决方案供应商",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-05-10",
            "original_text": "华大基因：收到2.83亿美元款项，NUPCO同时追加3817.6万美元金额合同",
            "features": {
                "keywords": [
                    "华大基因",
                    "NUPCO",
                    "合同",
                    "款项"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "华大基因：收到2.83亿美元款项，NUPCO同时追加3817.6万美元金额合同",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-05-10",
            "original_text": "华大基因：公司新冠检测产品已经覆盖全球超过180个国家和地区，海外累计运营“火眼”实验室超过80个，分布在近30个国家和地区",
            "features": {
                "keywords": [
                    "华大基因",
                    "新冠检测",
                    "火眼实验室",
                    "全球覆盖"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华大基因：公司新冠检测产品已经覆盖全球超过180个国家和地区，海外累计运营“火眼”实验室超过80个，分布在近30个国家和地区",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-05-10",
            "original_text": "国信证券 - 医药行业一周观察：21Q1成绩单已出，关注业绩持续兑现标的【行业研究】",
            "features": {
                "keywords": [
                    "国信证券",
                    "医药行业",
                    "21Q1",
                    "业绩兑现"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国信证券 - 医药行业一周观察：21Q1成绩单已出，关注业绩持续兑现标的【行业研究】",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]